As of 2025-07-12, the Intrinsic Value of Neximmune Inc (NEXI) is -2,914,540.00 USD. This NEXI valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.93 USD, the upside of Neximmune Inc is -74,161,425.00%.
Based on its market price of 3.93 USD and our intrinsic valuation, Neximmune Inc (NEXI) is overvalued by 74,161,425.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2,914,540.00 - -2,914,540.00 | -2,914,540.00 | -74,161,425.00% |
| P/E | (8,277,314.54) - (15,621,973.93) | (12,678,281.08) | -322602671.9% |
| DDM - Stable | (4,853,863.06) - (18,421,706.42) | (11,637,776.12) | -296126718.7% |
| DDM - Multi | (13,405,297.61) - (40,636,253.02) | (20,287,734.39) | -516227438.1% |
| Market Cap (mil) | 0.00 |
| Beta | 1.23 |
| Outstanding shares (mil) | 0.00 |
| Enterprise Value (mil) | -2.42 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.63% |
| Cost of Debt | 5.00% |
| WACC | 6.65% |